Disclaimer: This is an early beta prototype. If you find any error, with data or functionality, please let us know via this page.

Conditions

Interventions

Lay summary

- To evaluate the pharmacokinetics (PK) of brivaracetam (BRV) in neonates who have seizures that are not adequately controlled with phenobarbital (PB) treatment and to identify the optimum BRV dose (Exploratory Cohort) for the treatment of subjects enrolled into the Confirmatory Cohorts of this study - Evaluer la pharmacocinétique (PK) du brivaracetam (BRV) chez des nouveau-nés présentant des crises non contrôlées de manière satisfaisante grâce au traitement par PB et d’identifier la dose optimale de BRV (cohorte exploratoire) pour le traitement des patients inclus dans les cohortes confirmatoires de cette étude

Documents

 

Publications

We have no "publications" for this trial. Help us by contributing data.

Registries